Neurocrine Biosciences, Inc. · NASDAQ:NBIX

Morrow George J sold 15,000 Neurocrine Biosciences, Inc. shares (Form 4)

Traded Oct 30 to Nov 3, 2026 · Filed Nov 3, 2026

From Oct 30 to Nov 3, 2026, Morrow George J (Director) sold 15,000 Neurocrine Biosciences, Inc. shares at an average US$155.73 for US$2.34M under a trading plan, leaving 10,386 shares. Filed Nov 3, 2026 (Form 4).

Sold
15,000 shares
Price
US$155.73 average (US$144.98 to US$168.53)
Value
US$2.34M
Holding after
10,386 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 30, 2026Common StockOption exercise300US$53.6410,686Direct
Oct 30, 2026Common StockSale300US$149.0010,386Direct
Nov 2, 2026Common StockOption exercise7,500US$53.6417,886Direct
Nov 2, 2026Common StockSale1,900US$144.9815,986Direct
Nov 2, 2026Common StockSale4,300US$145.8611,686Direct
Nov 2, 2026Common StockSale1,300US$146.7610,386Direct
Nov 3, 2026Common StockOption exercise7,200US$53.6417,586Direct
Nov 3, 2026Common StockSale100US$158.1817,486Direct
Nov 3, 2026Common StockSale100US$162.0517,386Direct
Nov 3, 2026Common StockSale600US$163.7116,786Direct
Nov 3, 2026Common StockSale1,226US$164.7415,560Direct
Nov 3, 2026Common StockSale908US$165.7114,652Direct
Nov 3, 2026Common StockSale1,466US$166.7713,186Direct
Nov 3, 2026Common StockSale1,500US$167.7211,686Direct
Nov 3, 2026Common StockSale1,300US$168.5310,386Direct

Source

Download original · View original at SEC

Related